Replimune Group REPL 深 滬
等待開盤 09-20 09:30:00 美东时间
11.23
+0.150
+1.35%
華盛通- 最 高11.58
- 今 開11.32
- 成交量 65.25万股
- 最 低 11.07
- 昨 收 11.08
- 總市值 6.89亿
- 52周最高 17.14
- 市盈率 靜 --
- 換手率 1.06%
- 52周最低 4.92
- 委 比 -56.50%
- 總股本 6138.78万
- 歷史最高 54.79
- 量 比 0.93
- 振 幅 4.60%
- 歷史最低 4.92
- 每 手 1
- 風險率 2.83%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多快讯 | Replimune Group Inc：Jefferies将目标价从12美元提高至16美元。
Replimune Group Inc : Jefferies Raises Target Price to $16 From $12
09-18 12:29
Positive Outlook for Replimune’s RP1 Fuels Buy Rating Amidst Progress Toward Accelerated Approval
BMO Capital analyst Evan Seigerman maintained a Buy rating on Replimune Group (...
09-10 19:26
JP Morgan Maintains Overweight on Replimune Group, Lowers Price Target to $14
JP Morgan analyst Anupam Rama maintains Replimune Group (NASDAQ:REPL) with a Overweight and lowers the price target from $17 to $14.
08-13 20:35
Replimune Announces First Patient Randomized And Dosed In IGNYTE-3 Clinical Trial In Advanced Melanoma
Replimune Group, Inc. (NASDAQ:REPL), a clinical stage biotechnology company pioneering the development of a novel class of oncolytic immunotherapies, today announced that the first patient has been randomized and dosed
08-13 20:03
快讯 | Replimune Group公司: JP摩根将目标价从17美元降至14美元。
Replimune Group Inc : JP Morgan Cuts Target Price to $14 From $17
08-13 11:00
Possible Bearish Signals With Replimune Group Insiders Disposing Stock
Quite a few Replimune Group, Inc. (NASDAQ:REPL) insiders sold their shares over...
08-09 21:09
快讯 | Replimune集团公司提交文件，由出售股票的股东申请发行高达1134万股。-SEC提交
Replimune Group Inc Files for Offering of up to 11.34 Mln Shares by the Selling...
08-08 20:47
Replimune Group Q1 EPS $(0.78) Beats $(0.85) Estimate
Replimune Group (NASDAQ:REPL) reported quarterly losses of $(0.78) per share which beat the analyst consensus estimate of $(0.85) by 8.24 percent. This is a 4 percent decrease over losses of $(0.75) per share from the
08-08 20:43
Replimune Group GAAP EPS of -$0.78 beats by $0.09
Replimune Group press release (NASDAQ:REPL): Q1 GAAP EPS of -$0.78 beats by $0.09. As of June 30, 2024, cash, cash equivalents and short-term investments were $469.1 million, as compared to $420.7 mil...
08-08 20:42
新浪财经ESG：Replimune Group Inc. 路孚特（Refinitiv）ESG评级调降至D+
新浪财经ESG评级中心提供包括资讯、报告、培训、咨询等在内的14项ESG服务，助力上市公司传播ESG理念，提升ESG可持续发展表现。点击查看【 ESG评级中...
07-22 07:01
